Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selatogrel in Adults With Stable Coronary Artery Disease
NCT03384966Phase 2Completed
- Sponsor
- Viatris
- Start
- Jan 2018
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of selatogrel in coronary artery disease (CAD), sponsored by Viatris. Started Jan 2018; status: completed.
02
Drugs
selatogrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT03384966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03384966.